サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427954

末梢動脈疾患の世界市場レポート 2024年

Peripheral Artery Disease Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
末梢動脈疾患の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

末梢動脈疾患の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.3%の年間複合成長率（CAGR）で56億7,000万米ドルに成長すると予想されます。予測期間で予想される成長は、患者中心のケア、低侵襲処置の進歩、デジタルヘルスと遠隔モニタリングの統合、再生医療アプローチの進歩、標的薬物療法の採用への重点の集中に関連しています。この期間中に予想される注目すべき動向には、健康の公平性への取り組み、ウェアラブルデバイスの導入、在宅リハビリテーションの拡大、患者報告アウトカム（PRO）の重視、外来患者向けの明らかな移行などが含まれます。

末梢動脈疾患市場で予想される成長は、主に末梢動脈疾患の普及の増加によって促進されます。 末梢動脈疾患は、心臓の外側、特に脚の動脈の狭窄または閉塞を特徴とし、血流の減少と潜在的な合併症を引き起こします。 末梢動脈疾患の治療は、症状を軽減し、可動性を改善し、重篤な合併症のリスクを軽減することを目的としており、患者の健康状態の向上に貢献します。特に、2023年 4月のHMP Communications LLCのデータでは、末梢動脈疾患の普及率が世界的に上昇しており、1995年の1,130万人から2020年には2,100万人に増加し、2030年までに2,380万人に達すると予測されています。この普及率の上昇が、普及を推進する重要な要因です。

市場成長の重要な原動力は、高齢化人口の規模の拡大です。人口における高齢者の割合が着実に増加するにつれて、末梢動脈疾患の主要な危険因子であるアテローム性動脈硬化症を発症する可能性もそれに伴い増加しています。アテローム性動脈硬化症は、脂肪沈着物の蓄積による動脈の狭窄または閉塞を伴い、手足への血流の減少につながります。世界保健機関の2022年10月の報告書によると、世界の高齢化人口は大幅に増加し、2030年までに世界中の6人に1人が60歳以上になると予測されています。この人口動態の変化には、80歳以上の人の増加も伴います。その結果、人口の高齢化が末梢動脈疾患治療の需要を促進し、市場全体の成長に寄与すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の末梢動脈疾患市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の末梢動脈疾患の市場規模実績と成長率、2018～2023年
  • 世界の末梢動脈疾患市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の末梢動脈疾患市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 末梢血管形成術用バルーン
  • 末梢ステント
  • 末梢カテーテル
  • 下大静脈（IVC）フィルター
  • プラーク修正装置
  • 血行力学的な循環作動装置
  • 周辺付属品
  • 世界の末梢動脈疾患市場、医薬品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 脂質低下薬
  • 血圧降下薬
  • 血糖調節薬
  • 血栓予防薬
  • 循環作動薬
  • 血栓溶解剤
  • 抗炎症剤
  • 世界の末梢動脈疾患市場、投与経路別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 経口
  • 非経口
  • その他
  • 世界の末梢動脈疾患市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院
  • 専門クリニック
  • その他

第7章 地域と国の分析

  • 世界の末梢動脈疾患市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の末梢動脈疾患市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 末梢動脈疾患市場の競合情勢
  • 末梢動脈疾患市場の企業プロファイル
    • Cardinal Health Inc.
    • Vascular Solutions Inc.
    • Bayer AG
    • Abbott Laboratories
    • Medtronic plc.

第31章 その他の大手と革新的な企業

  • Koninklijke Philips NV（Royal Philips）
  • B. Braun Melsungen AG.
  • Terumo Corporation
  • Edwards Lifesciences
  • Becton Dickinson and Company（BD）
  • Boston Scientific Corporation Incorporated
  • Cook Group Incorporated
  • Merit Medical Systems Inc.
  • NuVasive Inc.
  • Arjo AB
  • Penumbra Inc.
  • BIOTRONIK SE and Co. KG
  • Natus Medical Inc.
  • AngioDynamics Inc.
  • Shockwave Medical Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r13798

Peripheral Artery Disease (PAD) is a condition characterized by the narrowing or blockage of arteries, predominantly affecting the limbs, especially the legs. Atherosclerosis, marked by the buildup of fatty deposits (plaques) within artery walls, is the primary cause, leading to diminished blood flow to the affected areas.

Key products in the peripheral artery disease market encompass peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Specifically, peripheral angioplasty balloons are medical devices engineered to expand narrowed or obstructed peripheral arteries. In the context of peripheral artery disease, these balloons play a crucial role in reopening arteries by inflating to compress plaques, ultimately widening the artery and restoring proper blood flow. Various pharmaceutical interventions involve lipid-lowering drugs, blood pressure-lowering drugs, glucose-regulating drugs, blood clot-preventing drugs, inotropes, thrombolytic agents, and anti-inflammatory agents. These medications are administered through diverse routes, including oral and parenteral, and cater to different end users such as hospitals, specialty clinics, and other healthcare facilities.

The peripheral artery disease market research report is one of a series of new reports from The Business Research Company that provides peripheral artery disease market statistics, including peripheral artery disease industry global market size, regional shares, competitors with a peripheral artery disease market share, detailed peripheral artery disease market segments, market trends and opportunities, and any further data you may need to thrive in the peripheral artery disease industry. This peripheral artery disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peripheral artery disease market size has grown strongly in recent years. It will grow from $3.97 billion in 2023 to $4.28 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The expansion observed during the historical period can be ascribed to several factors, including the rising prevalence of risk factors, a growing aging population, advancements in clinical research and evidence-based medicine, heightened awareness, and the implementation of screening programs. Additionally, government healthcare initiatives have played a significant role in fostering this growth.

The peripheral artery disease market size is expected to see strong growth in the next few years. It will grow to $5.67 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth in the forecast period is linked to a heightened focus on patient-centric care, progress in minimally invasive procedures, the integration of digital health and remote monitoring, advancements in regenerative medicine approaches, and the adoption of targeted drug therapies. Notable trends expected during this period encompass health equity initiatives, the incorporation of wearable devices, the expansion of home-based rehabilitation, the emphasis on patient-reported outcomes (PROs), and a discernible shift toward outpatient settings.

The anticipated growth in the peripheral artery disease market is primarily driven by the increasing prevalence of peripheral artery diseases. Peripheral artery disease, characterized by the narrowing or blockage of arteries outside the heart, particularly in the legs, results in diminished blood flow and potential complications. Treatment for peripheral artery disease aims to alleviate symptoms, improve mobility, and reduce the risk of severe complications, contributing to enhanced patient well-being. Notably, data from HMP Communications LLC in April 2023 revealed a global rise in peripheral artery disease prevalence, increasing from 11.3 million in 1995 to 21 million in 2020, with projections estimating it to reach 23.8 million by 2030. This upsurge in prevalence is a key factor propelling the growth of the peripheral artery disease market.

The significant driver for market growth is the expanding size of the aging population. As the proportion of older individuals in the population steadily rises, there is an associated increase in the likelihood of developing atherosclerosis, a major risk factor for peripheral artery disease. Atherosclerosis involves the narrowing or blockage of arteries due to the accumulation of fatty deposits, leading to reduced blood flow to the limbs. According to the World Health Organization's October 2022 report, the global aging population is expected to substantially increase, with 1 in 6 people worldwide projected to be aged 60 years or older by 2030. This demographic shift is accompanied by a rise in individuals aged 80 years or older, expected to triple between 2020 and 2050. Consequently, the aging population is anticipated to drive demand for peripheral artery disease treatments, contributing to the overall growth of the market.

The peripheral artery disease market is witnessing a significant trend towards technological advancements, with major companies adopting advanced surgical treatments to maintain their market positions. A notable example is Genesis MedTech Group, a Singapore-based medical device company, introducing the Chocolate Touch paclitaxel DCB catheter in November 2022. This percutaneous transluminal angioplasty (PTA) catheter is designed for treating patients with superficial femoral artery and popliteal artery disease. The Chocolate Touch drug-coated balloon, a pioneering catheter in the field, integrates therapeutic agent administration with a next-generation angioplasty platform for treating peripheral artery disease. It features pillow-such as structures covered with a therapeutic chemical, providing an alternative therapy to standard drug-coated balloon angioplasty. The unique design increases the balloon surface, enabling more effective medication delivery to the vessel wall and eliminating the need for permanent implants.

The growth of the peripheral artery disease market is expected to be propelled by increasing obesity rates. Obesity, characterized by the excess accumulation of body fat with negative health implications, is a significant contributing factor to peripheral artery disease (PAD). PAD involves the narrowing or blockage of blood vessels supplying blood to the legs, resulting in pain and difficulty walking. Notably, as of May 2022, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) reported that over 2 in 5 adults (42.4%) have obesity, with about 1 in 11 adults (9.2%) experiencing severe obesity. This upward trend in obesity rates is driving the demand for peripheral artery disease treatments.

In April 2023, Abbott Laboratories, a prominent US-based medical device company, acquired Cardiovascular Systems Inc. The acquisition, conducted for an undisclosed amount, expands and enriches Abbott's peripheral and coronary artery disease portfolio. Cardiovascular Systems Inc., a US-based medical device company specializing in manufacturing peripheral artery disease products, brings innovative atherectomy systems to further enhance Abbott's offerings in this medical domain.

Major companies operating in the peripheral artery disease market report are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, Natus Medical Inc., AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Lombard Medical Inc., Avinger Inc., Ra Medical Systems Inc.

North America was the largest region in the peripheral artery disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the peripheral artery disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral artery disease market consists of revenues earned by entities by providing peripheral artery disease management services and therapies such as diagnosis, angioplasty, atherectomy, lithoplasty, endovascular, vascular surgery, and rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The peripheral artery disease market also includes sales of guidewires, bare metal, drug-eluting, compression stockings, and exercise equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peripheral Artery Disease Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peripheral artery disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peripheral artery disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peripheral artery disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Peripheral Angioplasty Balloons; Peripheral Stents; Peripheral Catheters; Inferior Vena Cava (IVC) Filters; Plaque Modification Devices; Hemodynamic Flow Alteration Devices; Peripheral Accessories
  • 2) By Drugs: Lipid-Lowering Drugs; Blood Pressure Lowering Drugs; Glucose Regulating Drugs; Blood Clot Preventing Drugs; Inotropes; Thrombolytics Agents; Anti-Inflammatory Agents
  • 3) By Route of Administration: Oral; Parenteral; Other Routes of Administration
  • 4) By End Users: Hospitals; Specialty Clinics; Other End Users
  • Companies Mentioned: Cardinal Health Inc.; Vascular Solutions Inc.; Bayer AG; Abbott Laboratories; Medtronic plc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Peripheral Artery Disease Market Characteristics

3. Peripheral Artery Disease Market Trends And Strategies

4. Peripheral Artery Disease Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Peripheral Artery Disease Market Size and Growth

  • 5.1. Global Peripheral Artery Disease Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Peripheral Artery Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Peripheral Artery Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Peripheral Artery Disease Market Segmentation

  • 6.1. Global Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Peripheral Angioplasty Balloons
  • Peripheral Stents
  • Peripheral Catheters
  • Inferior Vena Cava (IVC) Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Peripheral Accessories
  • 6.2. Global Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lipid-Lowering Drugs
  • Blood Pressure Lowering Drugs
  • Glucose Regulating Drugs
  • Blood Clot Preventing Drugs
  • Inotropes
  • Thrombolytics Agents
  • Anti-Inflammatory Agents
  • 6.3. Global Peripheral Artery Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Routes of Administration
  • 6.4. Global Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End Users

7. Peripheral Artery Disease Market Regional And Country Analysis

  • 7.1. Global Peripheral Artery Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Peripheral Artery Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Peripheral Artery Disease Market

  • 8.1. Asia-Pacific Peripheral Artery Disease Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Peripheral Artery Disease Market

  • 9.1. China Peripheral Artery Disease Market Overview
  • 9.2. China Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Peripheral Artery Disease Market

  • 10.1. India Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Peripheral Artery Disease Market

  • 11.1. Japan Peripheral Artery Disease Market Overview
  • 11.2. Japan Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Peripheral Artery Disease Market

  • 12.1. Australia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Peripheral Artery Disease Market

  • 13.1. Indonesia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Peripheral Artery Disease Market

  • 14.1. South Korea Peripheral Artery Disease Market Overview
  • 14.2. South Korea Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Peripheral Artery Disease Market

  • 15.1. Western Europe Peripheral Artery Disease Market Overview
  • 15.2. Western Europe Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Peripheral Artery Disease Market

  • 16.1. UK Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Peripheral Artery Disease Market

  • 17.1. Germany Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Peripheral Artery Disease Market

  • 18.1. France Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Peripheral Artery Disease Market

  • 19.1. Italy Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Peripheral Artery Disease Market

  • 20.1. Spain Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Peripheral Artery Disease Market

  • 21.1. Eastern Europe Peripheral Artery Disease Market Overview
  • 21.2. Eastern Europe Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Peripheral Artery Disease Market

  • 22.1. Russia Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Peripheral Artery Disease Market

  • 23.1. North America Peripheral Artery Disease Market Overview
  • 23.2. North America Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Peripheral Artery Disease Market

  • 24.1. USA Peripheral Artery Disease Market Overview
  • 24.2. USA Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Peripheral Artery Disease Market

  • 25.1. Canada Peripheral Artery Disease Market Overview
  • 25.2. Canada Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Peripheral Artery Disease Market

  • 26.1. South America Peripheral Artery Disease Market Overview
  • 26.2. South America Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Peripheral Artery Disease Market

  • 27.1. Brazil Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Peripheral Artery Disease Market

  • 28.1. Middle East Peripheral Artery Disease Market Overview
  • 28.2. Middle East Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Peripheral Artery Disease Market

  • 29.1. Africa Peripheral Artery Disease Market Overview
  • 29.2. Africa Peripheral Artery Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Peripheral Artery Disease Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Peripheral Artery Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Peripheral Artery Disease Market Competitive Landscape And Company Profiles

  • 30.1. Peripheral Artery Disease Market Competitive Landscape
  • 30.2. Peripheral Artery Disease Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Vascular Solutions Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bayer AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Medtronic plc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Peripheral Artery Disease Market Other Major And Innovative Companies

  • 31.1. Koninklijke Philips N.V. (Royal Philips)
  • 31.2. B. Braun Melsungen AG.
  • 31.3. Terumo Corporation
  • 31.4. Edwards Lifesciences
  • 31.5. Becton Dickinson and Company (BD)
  • 31.6. Boston Scientific Corporation Incorporated
  • 31.7. Cook Group Incorporated
  • 31.8. Merit Medical Systems Inc.
  • 31.9. NuVasive Inc.
  • 31.10. Arjo AB
  • 31.11. Penumbra Inc.
  • 31.12. BIOTRONIK SE and Co. KG
  • 31.13. Natus Medical Inc.
  • 31.14. AngioDynamics Inc.
  • 31.15. Shockwave Medical Inc.

32. Global Peripheral Artery Disease Market Competitive Benchmarking

33. Global Peripheral Artery Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Peripheral Artery Disease Market

35. Peripheral Artery Disease Market Future Outlook and Potential Analysis

  • 35.1 Peripheral Artery Disease Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Peripheral Artery Disease Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Peripheral Artery Disease Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer